Inhibitors & Agonists

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC22037	Bobcat339 Featured	Bobcat339 (Bobcat 339) is a novel cytosine-based TET enzyme inhibitor with IC50 of 33 uM (TET1) and 73 uM (TET2), but not DNMT3a, does not inhibit the DNA methyltransferase DNMT3a.
DC23218	BOC-D-FMK Featured	BOC-D-FMK is a cell-permeable, irreversible, broad spectrum caspase inhibitor, inhibits apoptosis stimulated by TNF-α with IC50 of 39 uM.
DC5077	Boceprevir(EBP 520; SCH 503034 ) Featured	Boceprevir(EBP 520; SCH 503034 ) is useful for Anti HCV.
DC20034	Boc-MLF TFA	Boc-MLF (TFA) is a peptide, used as a specific formyl peptide receptor (FPR) antagonist, also inhibits the signaling through formyl peptide receptor like 1 (FPRL1) at higher concentrations.
DC8073	Bohemine Featured	Bohemine is a synthetic, cell-permeable, cyclin-dependent kinase inhibitor.
DC9547	Boldenone Undecylenate	Boldenone undecylenate(Equipoise) is a synthetic steroid which has a similar effect as the natural steroid testosterone; it is frequently used in veterinary medicine, though it is also used in humans.
DC1027	Bortezomib (Velcade,MG-341,PS-341) Featured	Bortezomib is a potent 20S proteasome inhibitor with Ki of 0.6 nM.
DC21869	Borussertib Featured	Borussertib is a potent, first-in-class, covalent-allosteric AKT inhibitor.
DC12405	BOS172722 Featured	BOS172722 (BOS-172722) is a potent, selective MPS1 kinase inhibitor with biochemical IC50 of 11 nM, 100-fold selectivity over CDK2.
DC9437	Bosentan	Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
DCAPI1483	Bosentan Hydrate	Bosentan is an endothelin (ET) receptors antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively.
DC5164	Bosutinib (SKI-606) Featured	Bosutinib is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity.
DC23896	Box5	Box5 is a Wnt5a-derived N-butyloxycarbonyl hexapeptide (t-Boc-Met-Asp-Gly-Cys-Glu-Leu), acts as an Wnt5a antagonist.
DC8883	BP897 Featured	BP897 is a partially selective D3 dopamine receptor agonist.
DC20322	BPIPP	BPIPP is an inhibitor of GC-C (guanylyl cyclase type C) that inhibits stimulation of guanylyl cyclase and adenylyl cyclase, suppresses cGMP accumulation in a variety of cell lines (IC50=3.4-11.2 uM).
DC11499	BPK-29	BPK-29 is a covalent, specific small molecule that disrupts NR0B1 protein complexes and impairs the anchorage-independent growth of KEAP1-mutant cancer cells.
DC12608	BPN14770 Featured	BPN14770 (BPN-14770) is an allosteric inhibitor of phosphodiesterase 4D (PDE4D) with IC50 of 7.8 and 7.4 nM for human PDE4D7 and PDE4D3 respectively, displays 16-fold less potent against monomeric form of PDE4D lacking the UCR1 dimerization domain (PDE4D2
DC23884	BPN-15606	BPN-15606 (BPN15606) is a highly potent, orally active γ-secretase modulator (GSM), attenuates the production of Aβ42 by SHSY5Y neuroblastoma cells with IC50 of 7 nM.
DC10387	BPO-27 racemat	BPO-27 racemate is a potent CFTR inhibitor with an IC50 of 8 nM.
DC8294	BPR1J-097 Featured	BPR1J-097 is a novel small molecule FLT-3 inhibitor(IC50=11±7 nM) with promising in vivo anti-tumour activities; inhibits FLT-3 D835Y with an IC50 of 3 nM.
DC21870	BPR1J373	BPR1J373 is a potent, orally available multitargeted kinase inhibitor, potently inhibits FLT3, c-KIT, VEGFR1-3, Aurora A, PDGFRα, PDGFRβ, RET, and SRC with IC50 values of <100 nM.
DC20825	BPR1K653	BPR1K653 is a novel potent Aurora kinase inhibitor that inhibits Aurora-A and Aurora-B with IC50 of 24 nM and 45 nM, respectively.
DC7951	Glutaminase Inhibitor II, BPTES Featured	BPTES is a selective inhibitor of Glutaminase GLS1 (KGA)
DC10618	BPTU Featured	BPTU is an Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM).
DC8392	BQ-123 Featured	BQ-123 is a selective endothelin A receptor (ETA) antagonist with IC50 of 7.3 nM. Phase 2.
DC7542	BQ-788 Featured	BQ-788 sodium salt is a potent, selective ETB receptor antagonist (IC50 = 1.2 nM for inhibition of ET-1 binding to human Girardi heart cells); poorly inhibited the binding to ET A receptors in human neuroblastoma cell line SK-N-MC cells (IC(50), 1300 nM).
DC10515	BQCA Featured	BQCA is a potent muscarinic M1 receptor positive allosteric modulator with selectivity for M1 over M2-M5.
DC23763	BQU-082	BQU-082 is a novel potent small GTPase Ral (Ras-like) inhibitor with IC50 of 1.7 uM, displays a dose dependent effect on RalA and RalB activity in H2122 spheroids using the common RalBP1 pull-down assay..
DC8202	BQU57 Featured	BQU57 is a potent and selective GTPase Ral Inhibitor.
DC12641	BR101549	BR101549 (BR-101549) is a novel PPARγ non-TZD agonist with EC50 of 1.73 uM (Amax 120%)..

Inhibitors & Agonists

Customized Consultation X

Your information is safe with us. * Required Fields.